Sell RIM!: Against ...
Arena Pharmaceuticals Inc. (ARNA: NASDAQ)
$6.43 0.03 | 0.47%
06/04/12 - 04:00 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 12.72M | 16.61M | 10.39M | 9.81M |
| Cost of Sales | -2.46M | -3.52M | -4.89M | -3.82M |
| Gross Operating Profit | 15.18M | 20.14M | 15.28M | 13.62M |
| Selling, General, and Administrative Expenses | 24.25M | 27.94M | 25.25M | 30.54M |
| Research & Development | 58.71M | 75.46M | 110.16M | 204.37M |
| Operating Income before D & A (EBITDA) | -67.77M | -83.26M | -120.13M | -221.28M |
| Depreciation & Amortization | 11.56M | 13.10M | 14.93M | 14.64M |
| Interest Income | 117.00K | 469.00K | 689.00K | 7.37M |
| Other Income - Net | -12.23M | -6.97M | 3.21M | -1.10M |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | -2.24M |
| Total Income Before Interest Expenses (EBIT) | -94.92M | -102.85M | -134.49M | -231.90M |
| Interest Expense | 14.31M | 21.68M | 18.72M | 5.68M |
| Pre-Tax Income | -109.22M | -124.53M | -153.20M | -237.57M |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -109.22M | -124.53M | -153.20M | -237.57M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -109.22M | -124.53M | -153.20M | -237.57M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -109.22M | -124.53M | -153.20M | -237.57M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-105.76M | -124.53M | -149.88M | -235.34M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -109.22M | -124.53M | -153.20M | -239.48M |
| Basic EPS from Continuing Ops. | -0.80 | -1.14 | -1.82 | -3.24 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.80 | -1.14 | -1.82 | -3.24 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.80 | -1.14 | -1.82 | -3.24 |
| Basic Normalized Net Income/Share | -0.77 | -1.14 | -1.78 | -3.21 |
| EPS fr Continuing Ops. | -0.80 | -1.14 | -1.82 | -3.24 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.80 | -1.14 | -1.82 | -3.24 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.80 | -1.14 | -1.82 | -3.24 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.77 | -1.14 | -1.78 | -3.21 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with ARNA
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- Userchrisnash69 Portfolio 1
- User1st Time out
- Userbio
- UserWIDELY HELD IN GAME
- Usermarket watch 2012
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- UserHoldings
- ContributorStocks Under-$10 Moving Hig...
Latest ARNA Headlines from TheStreet
- Stocks Under $10: Why I'm a Buyer
05.31.12 | 07:05 am - 4 Stocks Under $10 Making Big Moves 05.30.12 | 03:05 pm
- Arena Pharmaceuticals Inc. (ARNA): Today's Featured Health Care Loser 05.25.12 | 05:05 pm
- Biotech Stock Mailbag: ASCO, Celldex, Obesity Drug Game-Changer 05.25.12 | 05:05 am
- Outlooks for Pfizer, Arena and Onyx Following Busy May 05.21.12 | 07:05 am
- Biotech Stock Live Chat Recap: ASCO & Obesity 05.17.12 | 11:05 am
- Stocks Under $10: Healthcare Name on Sale
05.17.12 | 07:05 am - Hot Biotech Stocks Traded by Hedge Funds in First Quarter 05.16.12 | 07:05 am
- Arena Pharmaceuticals Inc. (ARNA): Today's Featured Health Care Winner 05.14.12 | 04:05 pm
- Mulling Arena Pharma's Future With Obesity Drug on Approval Path 05.14.12 | 03:05 pm
Press Releases for ARNA
- Arena Pharmaceuticals Investigated By Goldfarb Branham Law Firm LLP - Business Wire 10.08.10 | 09:10 am
- Girard Gibbs LLP Files Class Action Lawsuit Against Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) - Business Wire 09.29.10 | 05:09 pm
- Lieff Cabraser Heimann & Bernstein, LLP Announces Class Action Lawsuits Against Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) - Business Wire 09.28.10 | 02:09 pm
- Investor Notice: The Rosen Law Firm Announces Filing Of Securities Class Action Against Arena Pharmaceuticals, Inc. - ARNA - Business Wire 09.22.10 | 06:09 pm
- Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Arena Pharmaceuticals, Inc. - Business Wire 09.22.10 | 05:09 pm
- The Law Office Of Robbins Umeda LLP Announces An Investigation Of Arena Pharmaceuticals, Inc. - Business Wire 09.22.10 | 12:09 pm
Partner Headlines for ARNA
- Vivus' Qnexa Is Not Guaranteed Approval. Remember Provenge? - Benzinga 05.31.12 | 12:05 pm
- 4 Smaller Alternatives to Big Pharma Obesity Treatments - Benzinga 05.25.12 | 01:05 pm
- Pre-Market Most Active for May 22, 2012 : QQQ, NOK, FB, BBY, TEF, BAC, SNY, NVO, VOD, AAPL, ARNA, ZNGA - NASDAQ 05.22.12 | 12:05 pm
- Pre-Market Most Active for May 17, 2012 : SNY, BAC, BUD, MT, MTL, WMT, QQQ, VOD, AAPL, DNDN, ZNGA, ARNA - NASDAQ 05.17.12 | 12:05 pm
- Pre-Market Most Active for May 16, 2012 : CTL, SNY, BAC, GE, NCT, MT, QQQ, ARNA, SINA, PETD, ZNGA, RIMM - NASDAQ 05.16.12 | 12:05 pm
- After Hours Most Active for May 15, 2012 : DFG, TPX, JCP, GSM, QQQ, BAC, ARNA, CCJ, AIG, VELT, INTC, NWSA - NASDAQ 05.15.12 | 08:05 pm
- Pre-Market Most Active for May 14, 2012 : BAC, CHK, NOK, BBVA, CS, SIRI, JPM, ARNA, QQQ, YHOO, AAPL, FRAN - NASDAQ 05.14.12 | 12:05 pm
- Arena Pharmaceuticals: FDA Approval Is Just The Beginning - Seeking Alpha 05.13.12 | 09:05 am
- Benzinga's Top Upgrades with Color for May 11, 2012 - Benzinga 05.11.12 | 12:05 pm
- Social Media Outlook for Wednesday May 9 (PDC, DIS, STEC, FOSL) - Benzinga 05.09.12 | 01:05 pm





